HCM
IDXX icon

Howard Capital Management’s Idexx Laboratories IDXX Stock Holding History

Howard Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
2,396
+1,451
+154% +$814K 0.02% 241
2026
Q1 		$531K Sell
945
-1,131
-54% -$725K 0.01% 220
2025
Q4 		$1.4M Buy
2,076
+47
+2% +$32K 0.02% 197
2025
Q3 		$1.3M Sell
2,029
-6
-0.3% -$3.64K 0.02% 199
2025
Q2 		$1.09M Buy
2,035
+38
+2% +$18.2K 0.02% 211
2025
Q1 		$839K Sell
1,997
-307
-13% -$133K 0.02% 209
2024
Q4 		$953K Buy
2,304
+67
+3% +$29.4K 0.01% 220
2024
Q3 		$1.13M Buy
+2,237
New +$1.09M 0.02% 191
2020
Q4 		– Sell
-1,733
Closed -$681K – 57
2020
Q3 		$681K Buy
1,733
+115
+7% +$42.5K 0.16% 35
2020
Q2 		$548K Buy
+1,618
New +$468K 0.15% 33
2020
Q1 		– Sell
-2,224
Closed -$493K – 32
2019
Q4 		$493K Buy
2,224
+425
+24% +$112K 0.17% 25
2019
Q3 		$489K Buy
1,799
+2
+0.1% +$557 0.21% 24
2019
Q2 		$509K Sell
1,797
-153
-8% -$37.7K 0.23% 26
2019
Q1 		$438K Buy
+1,950
New +$403K 0.22% 31

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Howard Capital Management's IDXX Position: Q2 2026 in Review

Howard Capital Management increased its Idexx Laboratories (IDXX) stake by 154% in Q2 2026, buying an estimated $814K and bringing the position to 2,396 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #241.

Howard Capital Management first reported a position in IDXX in Q1 2019 and has held it in 14 quarters since. The position peaked at $1.4M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Howard Capital Management held 2,396 shares of Idexx Laboratories worth $1.26M as of Q2 2026.
  • Howard Capital Management bought 1,451 Idexx Laboratories shares in Q2 2026, an estimated $814K.
  • Idexx Laboratories made up 0.02% of Howard Capital Management's portfolio in Q2 2026, its #241 holding.
  • Howard Capital Management first reported a position in Idexx Laboratories in Q1 2019 and has held it in 14 quarters since.
  • Howard Capital Management's Idexx Laboratories position peaked at $1.4M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.